- Report
- March 2025
- 270 Pages
Global
From €4294EUR$4,799USD£3,717GBP
- Report
- March 2025
- 415 Pages
Global
From €4429EUR$4,950USD£3,834GBP
- Report
- July 2025
- 100 Pages
Global
From €2416EUR$2,700USD£2,091GBP
€2684EUR$3,000USD£2,323GBP
- Report
- May 2025
- 1200 Pages
Global
From €4832EUR$5,400USD£4,182GBP
€5369EUR$6,000USD£4,647GBP
- Report
- April 2025
- 190 Pages
Global
From €1933EUR$2,160USD£1,673GBP
€2147EUR$2,400USD£1,859GBP
- Report
- February 2025
- 100 Pages
Global
From €1933EUR$2,160USD£1,673GBP
€2147EUR$2,400USD£1,859GBP
- Report
- January 2025
- 150 Pages
Global
From €1933EUR$2,160USD£1,673GBP
€2147EUR$2,400USD£1,859GBP
- Report
- November 2024
- 240 Pages
Global
From €1933EUR$2,160USD£1,673GBP
€2147EUR$2,400USD£1,859GBP
- Report
- October 2024
- 180 Pages
Global
From €1933EUR$2,160USD£1,673GBP
€2147EUR$2,400USD£1,859GBP
- Report
- September 2024
- 240 Pages
Global
From €1933EUR$2,160USD£1,673GBP
€2147EUR$2,400USD£1,859GBP
- Report
- September 2024
- 210 Pages
Global
From €1933EUR$2,160USD£1,673GBP
€2147EUR$2,400USD£1,859GBP
- Clinical Trials
- July 2025
- 220 Pages
Global
From €2416EUR$2,700USD£2,091GBP
€2684EUR$3,000USD£2,323GBP
- Report
- January 2025
- 100 Pages
Global
From €1933EUR$2,160USD£1,673GBP
€2147EUR$2,400USD£1,859GBP
- Report
- May 2025
- 195 Pages
Global
From €3172EUR$3,545USD£2,746GBP
€3524EUR$3,939USD£3,051GBP
- Report
- May 2025
- 189 Pages
Global
From €3172EUR$3,545USD£2,746GBP
€3524EUR$3,939USD£3,051GBP
- Report
- May 2025
- 197 Pages
Global
From €3172EUR$3,545USD£2,746GBP
€3524EUR$3,939USD£3,051GBP
- Report
- May 2025
- 180 Pages
Global
From €3172EUR$3,545USD£2,746GBP
€3524EUR$3,939USD£3,051GBP
- Report
- May 2025
- 190 Pages
Global
From €3172EUR$3,545USD£2,746GBP
€3524EUR$3,939USD£3,051GBP
- Report
- May 2025
- 189 Pages
Global
From €3172EUR$3,545USD£2,746GBP
€3524EUR$3,939USD£3,051GBP
- Report
- May 2025
- 185 Pages
Global
From €3172EUR$3,545USD£2,746GBP
€3524EUR$3,939USD£3,051GBP

Early Phase Studies are a critical part of the drug discovery process. They are the first step in the clinical development of a drug, and involve the testing of a drug's safety, efficacy, and pharmacokinetics in humans. Early Phase Studies are typically conducted in small groups of healthy volunteers or patients, and involve the administration of a single dose or multiple doses of the drug. The results of these studies are used to determine whether the drug is safe and effective for further clinical development.
Early Phase Studies are conducted by a variety of companies, including contract research organizations (CROs), pharmaceutical companies, and biotechnology companies. These companies provide services such as clinical trial design, data management, and regulatory support. They also provide expertise in drug development, clinical trial management, and regulatory compliance.
Some of the companies in the Early Phase Study market include Parexel, Quintiles, Covance, PPD, ICON, and Syneos Health. Show Less Read more